Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience

M Elwazir, ML Krause, JP Bois, G Christopoulos… - Journal of Cardiac …, 2022 - Elsevier
Background We sought to examine the effect of anti–B-cell therapy (rituximab) on cardiac
inflammation and function in corticosteroid-refractory cardiac sarcoidosis. Cardiac …

[HTML][HTML] The Role of 18F-FDG PET/CT in Cardiac Sarcoidosis

C Wiefels, O Lamai, R Kandolin, D Birnie… - International Journal of …, 2020 - SciELO Brasil
Cardiac sarcoidosis (CS) is a rare and potentially fatal condition, characterized by the
presence of non-necrotizing granulomatous inflammation and concomitant fibrosis. A variety …